Geron Corp
Change company Symbol lookup
Select an option...
GERN Geron Corp
CLERX AdvisorOne CLS Growth and Income Fund Class N
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
CNBS Amplify Seymour Cannabis ETF
RBCAA Republic Bancorp Inc
IMTE Integrated Media Technology Ltd
GECC Great Elm Capital Corp
SCX L S Starrett Co
VFIAX Vanguard 500 Index Fund Admiral Shares
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Geron Corporation (Geron) is a late-stage clinical biopharmaceutical company, which is focused on development and commercialization of imetelstat, a therapeutic for hematologic myeloid malignancies. The Company operates through a single segment, which is engaged in the development therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. The clinical studies of imetelstat includes IMerge, a Phase II/III trial in lower risk myelodysplastic syndromes (MDS) and IMbark, a Phase II trial in Intermediate- II or High-risk myelofibrosis.

Closing Price
$2.19
Day's Change
0.06 (2.82%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.27
Day's Low
2.10
Volume
(Below Average)
Volume:
3,372,446

10-day average volume:
3,816,383
3,372,446
  • Prev Close
    2.13
  • Today's Open
    2.11
  • Day's Range
    2.10-2.27
  • Avg Vol (10-day)
    3.8M
  • Last (time)
    4:00p ET 07/07/20
  • Last (size)
    239
  • 52-Wk Range
    0.75 - 2.40
    LowHigh
  • (03/16/20 - 05/18/20)
    8.75%
  • 68.1%
  • Market Cap
    679.7M
  • Shares Outstanding
    310.4M
  • -0.38
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.8
  • 58.15
  • (% of float 06/15/20)
    9.52

Latest News

July 01, 2020
8:30 am ET
Globe Newswire
June 12, 2020
8:30 am ET
Globe Newswire
May 28, 2020
4:12 pm ET
Globe Newswire
May 27, 2020
4:30 pm ET
Globe Newswire
May 22, 2020
8:13 am ET
MarketWatch
7:15 am ET
Globe Newswire
May 21, 2020
4:03 pm ET
Globe Newswire
4:01 pm ET
Globe Newswire
8:30 am ET
BusinessWire
May 14, 2020
9:05 am ET
BusinessWire
April 20, 2020
11:50 am ET
BusinessWire
April 16, 2020
8:30 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.